Patent · US Active

Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins

US10160793B2 · kind B2 · utility

5Cited by

54References

30Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Justin Scheer · San Francisco, US
Wenjun Ouyang · Foster City, US
Richard Vandlen · Hillsborough, US
Philip E. Hass · Moss Beach, US
Eric Gary Stefanich · Emerald Hills, US
Xiaoting Wang · Berkeley, US

Key dates

Filing date	Mar 14, 2014
Grant date	Dec 25, 2018
Priority date	—
Expiry date	Sep 3, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.